Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM

NCT06547619 is registered in ClinicalTrials.gov with Anna Stanhewicz, PhD as lead sponsor.

NCT NCT06547619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06547619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM
Lead sponsor
Anna Stanhewicz, PhD
Phase
Phase 1
Overall status
Recruiting
Start date
October 1, 2024
Completion date
May 31, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endothelial dysfunction, gestational diabetes, physical inactivity